HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dewaraja, Y. K. Articles by Kaminiski, M. S. Search for Related Content PubMed PubMed Citation Articles by Dewaraja, Y. K. Articles by Kaminiski, M. S.

Accurate Dosimetry in ¹³¹I Radionuclide Therapy Using Patient-Specific, 3-Dimensional Methods for SPECT Reconstruction and Absorbed Dose Calculation

¹ Division of Nuclear Medicine, Department of Radiology, The University of Michigan Medical Center, Ann Arbor, Michigan
² Department of Medical Radiation Physics, University of Lund, Lund, Sweden
³ Pfizer Global Research and Development, Ann Arbor, Michigan
⁴ Division of Hematology and Oncology, Department of Internal Medicine, The University of Michigan Medical Center, Ann Arbor, Michigan

¹³¹I radionuclide therapy studies have not shown a strong relationship between tumor absorbed dose and response, possibly due to inaccuracies in activity quantification and dose estimation. The goal of this work was to establish the accuracy of ¹³¹I activity quantification and absorbed dose estimation when patient-specific, 3-dimensional (3D) methods are used for SPECT reconstruction and for absorbed dose calculation. Methods: Clinically realistic voxel-phantom simulations were used in the evaluation of activity quantification and dosimetry. SPECT reconstruction was performed using an ordered-subsets expectation maximization (OSEM) algorithm with compensation for scatter, attenuation, and 3D detector response. Based on the SPECT image and a patient-specific density map derived from CT, 3D dosimetry was performed using a newly implemented Monte Carlo code. Dosimetry was evaluated by comparing mean absorbed dose estimates calculated directly from the defined phantom activity map with those calculated from the SPECT image of the phantom. Finally, the 3D methods were applied to a radioimmunotherapy patient, and the mean tumor absorbed dose from the new calculation was compared with that from conventional dosimetry obtained from conjugate-view imaging. Results: Overall, the accuracy of the SPECT-based absorbed dose estimates in the phantom was >12% for targets down to 16 mL and up to 35% for the smallest 7-mL tumor. To improve accuracy in the smallest tumor, more OSEM iterations may be needed. The relative SD from multiple realizations was <3% for all targets except for the smallest tumor. For the patient, the mean tumor absorbed dose estimate from the new Monte Carlo calculation was 7% higher than that from conventional dosimetry. Conclusion: For target sizes down to 16 mL, highly accurate and precise dosimetry can be obtained with 3D methods for SPECT reconstruction and absorbed dose estimation. In the future, these methods can be applied to patients to potentially establish correlations between tumor regression and the absorbed dose statistics from 3D dosimetry.

Key Words: 3-dimensional dosimetry • radioimmunotherapy • SPECT • Monte Carlo dosimetry • ¹³¹I

Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 8a-9a. [Full Text]  

This article has been cited by other articles:

				R. Accorsi, J. S. Karp, and S. Surti Improved Dose Regimen in Pediatric PET J. Nucl. Med., February 1, 2010; 51(2): 293 - 300. [Abstract] [Full Text] [PDF]

				P. Bourgeois A Proposition for the Use of Radioiodine in WDTC Management J. Nucl. Med., February 1, 2009; 50(2): 328 - 329. [Full Text] [PDF]

				A. Divoli, S. Chiavassa, L. Ferrer, J. Barbet, G. D Flux, and M. Bardies Effect of Patient Morphology on Dosimetric Calculations for Internal Irradiation as Assessed by Comparisons of Monte Carlo Versus Conventional Methodologies J. Nucl. Med., February 1, 2009; 50(2): 316 - 323. [Abstract] [Full Text] [PDF]

				M. T. Madsen Recent Advances in SPECT Imaging J. Nucl. Med., April 1, 2007; 48(4): 661 - 673. [Abstract] [Full Text] [PDF]

				Y. Du, J. Honeychurch, M. Glennie, P. Johnson, and T. Illidge Microscopic Intratumoral Dosimetry of Radiolabeled Antibodies Is a Critical Determinant of Successful Radioimmunotherapy in B-Cell Lymphoma Cancer Res., February 1, 2007; 67(3): 1335 - 1343. [Abstract] [Full Text] [PDF]

				H. Song, B. He, A. Prideaux, Y. Du, E. Frey, W. Kasecamp, P. W. Ladenson, R. L. Wahl, and G. Sgouros Lung Dosimetry for Radioiodine Treatment Planning in the Case of Diffuse Lung Metastases J. Nucl. Med., December 1, 2006; 47(12): 1985 - 1994. [Abstract] [Full Text] [PDF]